Bruno Schoentjes
About Bruno Schoentjes
Bruno Schoentjes is the Associate Director of Oncology Medical Affairs at Bristol-Myers Squibb and has extensive experience in medicinal chemistry and oncology, having held various roles at Janssen and Sanofi.
Current Roles
Bruno Schoentjes is currently associated with multiple roles in the medical and pharmaceutical industry. He serves as the Associate Director of Oncology Medical Affairs at Bristol-Myers Squibb. Additionally, he works as a Medical Advisor Oncology focusing on solid tumours for Janssen Europe, Middle East & Africa (EMEA). His profile also includes roles at Janssen Pharmaceutical Companies of Johnson & Johnson, where he operates as a Medical Scientific Liaison for Immunology, in charge of investigator studies and scientific partnerships, as well as for Immunology and Diabetes in Raritan, New Jersey, United States.
Past Experience in Medicinal Chemistry
Bruno Schoentjes has extensive experience in medicinal chemistry, having held significant roles at Janssen and Sanofi. He was a Principal Scientist and Team Leader in Medicinal Chemistry at Janssen Inc. from 2009 to 2014 and served as Team Leader in the same field from 2002 to 2009. Before his tenure at Janssen, Bruno was the Laboratory Head in Medicinal Chemistry at Sanofi-Synthelabo in Strasbourg, France from 2000 to 2002. He also worked as a Medicinal Chemist at Sanofi from 1994 to 1999.
Educational Background
Bruno Schoentjes completed his doctorate (Doctor of Philosophy) at Université Louis Pasteur (Strasbourg I) between 1990 and 1993. This advanced education paved the way for his career in medicinal chemistry and medical affairs, equipping him with a strong foundation in scientific research and leadership.
Experience in Oncology Medical Affairs
Since November 2018, Bruno Schoentjes has been actively working in the field of oncology medical affairs. His current role as Associate Director Oncology Medical Affairs at Bristol-Myers Squibb highlights his expertise and commitment to advancing oncology healthcare. His work in this domain focuses on bridging scientific research with practical medical applications to improve patient outcomes.
Roles Focused on Immunology and Diabetes
Bruno Schoentjes has undertaken multiple roles that emphasize his specialization in immunology and diabetes. At Janssen Pharmaceutical Companies of Johnson & Johnson, he serves as a Medical Scientific Liaison for Immunology, overseeing investigator studies and scientific partnerships. His responsibilities extend to managing similar liaisons for both Immunology and Diabetes based in Raritan, New Jersey.